Lightwave Logic Inc   (LWLG)
Other Ticker:  
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
Price: $4.2200 $0.01 0.238%
Day's High: $4.32 Week Perf: -8.06 %
Day's Low: $ 4.17 30 Day Perf: -3.65 %
Volume (M): 461 52 Wk High: $ 9.18
Volume (M$): $ 1,945 52 Wk Avg: $5.41
Open: $4.26 52 Wk Low: $3.79

 Market Capitalization (Millions $) 492
 Shares Outstanding (Millions) 116
 Employees 10
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 2

Lightwave Logic Inc

We were incorporated under the laws of the State of Nevada on June 24, 1997 and in 2004 we acquired PSI-TEC Corp., and in 2006 we merged with PSI-TEC Corp. PSI-TEC Corp. was originally founded by Dr. Frederick J. Goetz in 1991 and incorporated under the laws of the State of Delaware on September 12, 1995. In 2008 we changed our name to Lightwave Logic, Inc.

Lightwave Logic, Inc. is a development stage company whose P2ICTM technology addresses advanced telecommunication, data communications, and data center markets utilizing its advanced organic electro-optic polymer systems. The Company currently has two business segments to support its development activities, its materials development segment located in Newark, Delaware, and its photonic device design and development segment located in Longmont, Colorado.

The Company designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs. A polymer system is not solely a material, but also encompasses various technical enhancements necessary for its implementation. These include host polymers, poling methodologies, and molecular spacer systems that are customized to achieve specific optical properties. Our organic electro-optic polymer systems compounds are mixed into solution form that allows for thin film application. Our proprietary electro-optic polymers are designed at the molecular level for potentially superior performance, stability and cost-efficiency. We believe they have the potential to replace more expensive, lower-performance materials and devices used in fiber-optic ground, wireless and satellite communication networks.

Our patented and patent pending molecular architectures are based on a well-understood chemical and quantum mechanical occurrence known as aromaticity. Aromaticity provides a high degree of molecular stability that enables our core molecular structures to maintain stability under a broad range of polymerization conditions that otherwise appear to affect other current polymer molecular designs.

We expect our patented and patent-pending optical materials along with trade secrets and licensed materials, to be the core of and the enabling technology for future generations of optical devices, modules, sub-systems and systems that we will develop or potentially out-license to electro-optic device manufacturers. The Company contemplates future applications that may address the needs of semiconductor companies, aerospace companies and government agencies.

Lightwave Logic, Inc. is developing next generation proprietary photonic devices that are based on our advanced electro-optical polymer material systems. Current legacy technology is based on inorganic crystalline materials, which has allowed for the proliferation of data over fiber optic cables. However, there are inherent molecular deficiencies that have prevented this technology from scaling down in price and up in functionality. This is primarily due to a closed valence structure that does not allow for the molecular improvements. The valence or valency of an element is a measure of its combining power with other atoms when it forms chemical compounds or molecules. Also, the physical properties of a crystal do not allow for its implementation into highly miniaturize slot structures that are in simple terms the pathways that light travels through in the device.

Organic polymer materials on the other hand, have free electrons that allow for limitless potential to combine with other molecular structures, which allows for multiple options and combinations to improving performance characteristics. Importantly, because they can be applied to optical structures in thin-film liquid form, it is possible to imbue electro-optic ability to highly miniaturized slot structures. Organic polymer materials are also vastly cheaper to manufacture in comparison to growing exotic crystals that are prone to contamination and further must be sliced into thin wafers. Our Company believes that the combination of less expensive manufacturing cost, ease of application, and better scalability, together with a lower cost of ownership due to marked less heat dissipation (requiring less cooling), will create enormous demand for our products.

   Company Address: 369 Inverness Parkway Englewood 80112 CO
   Company Phone Number: 340-4949   Stock Exchange / Ticker: NASDAQ LWLG
   LWLG is expected to report next financial results on February 29, 2024.

Customers Net Income grew by LWLG's Customers Net Profit Margin grew to

45.17 %

26.99 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
BDC        4.79% 
BHE        1.45% 
COMM   -6.73%    
PLXS        1.03% 
TEL        2.07% 
WIRE        2.44% 
• View Complete Report

Lightwave Logic Inc

Unveiling Disturbing Trends: Medical Laboratories Company's Troubling Business Behavior Sends Shockwaves Across Fiscal Span Ending Q3, 2023

In the highly competitive Medical Laboratories industry, big players have long dominated the market. However, there is a growing trend of smaller businesses entering the arena, hoping to make their mark. Lightwave Logic Inc (LWLG) is one such company that has recently announced its operating loss for the third quarter of 2023. Although specific revenue figures remain undisclosed, it is vital to compare the current performance with the previous year to gain a better understanding of the company's growth trajectory. As LWLG strives to establish prosperous revenue streams, it is important to examine its financial standings and evaluate future prospects carefully.
Operating Loss: A Short-Term Setback
During the third quarter of 2023, Lightwave Logic Inc recorded an operating loss of $-5.386276 million, marking a decline when compared to the corresponding period in 2022, where the operating loss stood at $-4.732316 million. While these figures might raise concerns, it is crucial to consider the challenges faced by growing businesses in an evolving market.

Lightwave Logic Inc

Lightwave Logic Inc (LWLG) Faces Uphill Battle as Operating Deficit Soars, Leaving Investors Wondering When Revenue Will Flow

Lightwave Logic Inc (LWLG) is a company operating in the Medical Laboratories industry, and it has recently released its financial results for the second quarter of the 2023 earnings season. The company announced an operating deficit of $-5.3407 million, which is a significant increase from the operating deficit of $-3.768352 million in the second quarter of 2022.
These financial figures have raised questions among investors regarding when LWLG will start generating revenue. Developing a prosperous business model often involves overcoming some challenges along the way, and the fiscal second quarter of 2023 seems to be one of those bumpy periods for LWLG. The operating deficit has further widened to $-5.458 million.

Lightwave Logic Inc

Lightwave Logic Inc Faces Mounting Financial Challenges as Analysts Question Revenue Growth

Lightwave Logic Inc Reports Operating Loss While Analysts Await Revenue Growth
In a recent report, Lightwave Logic Inc - a small medical laboratories company - revealed its operating loss of $-5.159877 million for the first quarter of 2023. The operating loss has worsened from $-3.510568 million for the same period in 2022, an alarming trend that has raised concerns among analysts.
While the loss is significant, analysts are now wondering when Lightwave Logic Inc will start to show revenue growth. The company's CFO is said to be exploring different business models in an attempt to ensure a constant product line. Investors and industry experts await their next move as the medical sector continues to evolve at a rapid pace.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com